tiprankstipranks
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market

Senti Biosciences (SNTI) Income Statement

246 Followers

Senti Biosciences Income Statement

Last quarter (Q4 2025), Senti Biosciences's total revenue was $22.00K, an increase of Infinity% from the same quarter last year. In Q4, Senti Biosciences's net income was $-14.47M. See Senti Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 22.00K$ 0.00$ 1.98M$ 3.29M$ 2.29M
Gross Profit
$ -3.62M$ 0.00$ 1.98M$ 3.29M$ 2.29M
Operating Expenses
$ 60.11M$ 61.04M$ 94.70M$ 65.37M$ 42.74M
Depreciation and Amortization
$ 3.64M$ 5.85M$ 5.43M$ 3.92M$ 3.01M
EBITDA
$ -60.09M$ -54.88M$ -61.34M$ -58.16M$ -37.44M
Operating Income
$ -63.73M$ -61.04M$ -92.73M$ -62.08M$ -40.45M
Other Income/Expenses
$ 2.29M$ 8.25M$ 9.32M$ 12.42M$ -14.87M
Pretax Income
$ -61.44M$ -52.79M$ -83.41M$ -49.66M$ -55.32M
Net Income
$ -61.44M$ -52.79M$ -71.06M$ -58.21M$ -55.32M
Per Share Metrics
Basic EPS
$ -2.73$ -11.49$ -20.94$ -13.25$ -12.67
Diluted EPS
$ -2.73$ -11.49$ -20.94$ -13.25$ -12.67
Weighted Average Shares Outstanding
224.83M 4.60M 4.44M 4.39M 4.37M
Weighted Average Shares Outstanding (Diluted)
224.83M 4.60M 4.44M 4.39M 4.37M
Currency in USD

Senti Biosciences Earnings and Revenue History